Abstract
SM-1 is a murine monoclonal antibody strongly reactive with a cell membrane antigen of small cell carcinoma (SCC) of the lung but unreactive with the membrane of most other carcinomas and normal tissues including normal bone marrow. We have found that in the presence of human complement, SM-1 antibody is highly cytotoxic to SCC cells. Using three treatments with antibody and complement, more than 99% of SCC cells in culture were lysed, as determined by the chromium release and clonogenic assays. Similar efficiency of SCC cell lysis was observed when one SM-1 antibody treatment was followed by three treatments with human complement. In contrast, there was little antibody-dependent lysis of non-small cell lung cancer cells, other carcinomas, and leukemia cell lines. The amount of chromium released from normal bone marrow cells treated with SM-1 antibody and complement was minimal and was mainly due to the effect of complement alone. Clonogenic assays, including colony-forming unit-granulocytic/monocytic, erythroid burst-forming unit, and colony-forming unit-granulocytic/erythroid/monocytic/megakaryocytic, also showed no significant SM-1 antibody-dependent cytotoxicity on normal bone marrow precursors. Since SM-1 antibody is selectively cytotoxic to SCC cells in the presence of human complement, it is a potentially useful agent for the selective eradication of tumor cell contamination in marrows of patients with metastatic small cell lung cancer and possibly for in vivo serotherapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bast R. C., Jr, Ritz J., Lipton J. M., Feeney M., Sallan S. E., Nathan D. G., Schlossman S. F. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Cancer Res. 1983 Mar;43(3):1389–1394. [PubMed] [Google Scholar]
- Bernal S. D., Speak J. A. Membrane antigen in small cell carcinoma of the lung defined by monoclonal antibody SM1. Cancer Res. 1984 Jan;44(1):265–270. [PubMed] [Google Scholar]
- Bernard A., Boumsell L., Borsos Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells. J Immunol. 1975 Oct;115(4):1091–1094. [PubMed] [Google Scholar]
- Cohen M. H., Matthews M. J. Small cell bronchogenic carcinoma: a distinct clinicopathologic entity. Semin Oncol. 1978 Sep;5(3):234–243. [PubMed] [Google Scholar]
- Glode L. M., Robinson W. A., Hartmann D. W., Klein J. J., Thomas M. R., Morton N. Autologous bone marrow transplantation in the therapy of small cell carcinoma of the lung. Cancer Res. 1982 Oct;42(10):4270–4275. [PubMed] [Google Scholar]
- Griffin J. D., Ritz J., Beveridge R. P., Lipton J. M., Daley J. F., Schlossman S. F. Expression of MY7 antigen on myeloid precursor cells. Int J Cell Cloning. 1983 Apr;1(1):33–48. doi: 10.1002/stem.5530010106. [DOI] [PubMed] [Google Scholar]
- Hansen M., Hansen H. H., Dombernowsky P. Long-term survival in small cell carcinoma of the lung. JAMA. 1980 Jul 18;244(3):247–250. [PubMed] [Google Scholar]
- Souhami R. L., Harper P. G., Linch D., Trask C., Goldstone A. H., Tobias J., Spiro S. G., Geddes D. M., Richards J. D. High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus. Cancer Chemother Pharmacol. 1982;8(1):31–34. doi: 10.1007/BF00292868. [DOI] [PubMed] [Google Scholar]
- Spitzer G., Dicke K. A., Litam J., Verma D. S., Zander A., Lanzotti V., Valdivieso M., McCredie K. B., Samuels M. L. High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors. Cancer. 1980 Jun 15;45(12):3075–3085. doi: 10.1002/1097-0142(19800615)45:12<3075::aid-cncr2820451233>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- Stahel R. A., Takvorian R. W., Skarin A. T., Canellos G. P. Autologous bone marrow transplantation following high-dose chemotherapy with cyclophosphamide, BCNU and VP-16 in small cell carcinoma of the lung and a review of current literature. Eur J Cancer Clin Oncol. 1984 Oct;20(10):1233–1238. doi: 10.1016/0277-5379(84)90252-9. [DOI] [PubMed] [Google Scholar]
- Stewart P., Buckner C. D., Thomas E. D., Bagley C., Bensinger W., Clift R. A., Appelbaum F. R., Sanders J. Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung. Cancer Treat Rep. 1983 Dec;67(12):1055–1059. [PubMed] [Google Scholar]